Two US companies ink deals to expand biosimilar offerings
In the past week, two companies have signed on with Biosimilars Solutions to help the ease of access and affordability of the drugs.
OcyonBio and Evio Pharmacy Solutions both rolled out strategies to cut costs.
OcyonBio, based in Aguadilla, Puerto Rico, will use its 95,000-square-feet of cleanroom and biomanufacturing space to usher in the biosimilars to the US. Biosimilar Solutions will streamline control over cGMP production in a site that has already been inspected by the FDA and EMA, among other regulators.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
